First, I would like to thank Dr Haddad for his interest in my editorial. However, I believe that we will need to see the full text of his manuscript regarding his experience with the treatment of radioiodine and antithyroid medication. Unfortunately, with only a table and a brief description of Dr Haddad's cases, we do not know if this was a prospective study, nor do we know what the inclusion/exclusion factors were, how the treatment differed between the 2 groups, if prednisone therapy was used in any of the groups, or what the incidence of smoking was in each group; also, a variety of other inclusion/exclusion information is not included in Dr Haddad's letter.
Keltner JL. Graves Ophthalmopathy. Arch Ophthalmol. 1999;117(5):700. doi: